ARO-HIF2 shows promise for advanced kidney cancer By Sharon Deveson Kell|2021-07-16T07:41:26+00:0016 Jul 2021|Drug treatments| A small phase 1b study of a new medicine called [...] Read More Comments Off on ARO-HIF2 shows promise for advanced kidney cancer
New class of kidney cancer drugs potentially more effective than sunitinib By Sharon Kell|2016-09-06T16:24:41+00:006 Sep 2016|Cancer news| A recent pre-clinical study published in the journal Nature shows that [...] Read More Comments Off on New class of kidney cancer drugs potentially more effective than sunitinib